Following a review of its global business pharmaceutical company Sanofi announced the intention to close its manufacturing plant at Fawdon in the north-east of England.
Sanofi had a commitment to approaching site closure in a way that treats staff fairly and recognises the company’s Corporate Social Responsibility.
Sanofi appointed SOG’s Fusion Team to consider the various options for Fawdon in the lead up to closure. SOG was selected due to its success in coordinating the sale and regeneration of a major Sanofi manufacturing site in Dagenham, east London, which led to SOG creating Londoneast-uk Business and Technical Park.